Retrospective Real-World Adherence in Patients With Type 2 Diabetes Initiating Once-Daily Liraglutide 1.8 mg or Twice-Daily Exenatide 10 μg
- Resource Type
- Article
- Source
- In
Clinical Therapeutics June 2013 35(6):795-807 - Subject
- Language
- ISSN
- 0149-2918